Boston Beer Company is a leading craft brewer known for its innovative brewing techniques and a diverse portfolio of alcoholic beverages, including its flagship Samuel Adams beer. The company focuses on producing high-quality, handcrafted beers and has expanded its offerings to include hard seltzers, ciders, and ready-to-drink cocktails, catering to a wide variety of consumer tastes. Through a commitment to brewing excellence and sustainability, Boston Beer Company has become a significant player in the beverage industry, continually seeking to enhance its products while promoting responsible alcohol consumption.
Boston Beer has been treading water for the past six months, recording a small return of 3.4% while holding steady at $313.04. The stock also fell short of the S&P 500’s 14% gain during that period.
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the beverages, alcohol and tobacco stocks, including Coca-Cola (NYSE:KO) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how beverages, alcohol and tobacco stocks fared in Q3, starting with Monster (NASDAQ:MNST).
Looking back on beverages, alcohol and tobacco stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Tilray Brands (NASDAQ:TLRY) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Cal-Maine (NASDAQ:CALM) and its peers.
Boston Beer Company sees increased analyst confidence after Q3 results, driven by strong margin control and growth potential, despite ongoing volume challenges.
Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), the owner of RISE Dispensaries, announced on Monday a $50 million share repurchase program.The company's board of directors gave the green light to the repurchase program which authorizes, under a normal course issuer bid, the repurchase of up to 10,573,860 of its subordinate voting shares from time to time over the next 12 months.The repurchase program will commence on Sept. 23, 2024, and expire on Sept. 22, 2025. Green Thumb's previous repurchase program expired on Sept. 10, 2024, under which the company repurchased 6.5 million shares for $73.3 million.
Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), the owner of RISE Dispensaries announced on Thursday it has closed on a $150 million 5-year syndicated credit facility led by Valley National Bank, the principal subsidiary of Valley National Bancorp. What Happened: The notes have a maturity date of Sept. 11, 2029 and will bear interest from the date of issue at a secured overnight financing rate (SOFR) + 500 basis points, payable quarterly.The company said the transaction did not involve the issuance of any Green Thumb equity to any of the participating banks.
